Correction to: Abnormally elevated USP37 expression in breast cancer stem cells regulates stemness, epithelial-mesenchymal transition and cisplatin sensitivity

Tao Qin1,2, Bai Li1,2, Xiaoyue Feng1,2, Shujun Fan1,2, Lei Liu3, Dandan Liu1,2, Jun Mao1,2, Ying Lu4, Jinfeng Yang5, Xiaotang Yu1, Qingqing Zhang1, Jun Zhang6, Bo Song1,2, Man Li7, Lianhong Li1,2
1Department of Pathology, Dalian Medical University, Dalian, People’s Republic of China
2The Key Laboratory of Tumor Stem Cell Research of Liaoning Province, Dalian Medical University, Dalian, People’s Republic of China
3Department of Urology, The First Affiliated Hospital of Dalian Medical University, Dalian, People’s Republic of China
4Teaching Laboratory of Morphology, Dalian Medical University, Dalian, People’s Republic of China
5Department of Pathology, Xiangyang Central Hospital, Xiangyang, People’s Republic of China
6Department of Dean, Dalian Medical University, Dalian, People’s Republic of China
7Department of Oncology, The Second Affiliated Hospital of Dalian Medical University, Dalian, People’s Republic of China

Tài liệu tham khảo

Qin T, Li B, Feng X, et al. Abnormally elevated USP37 expression in breast cancer stem cells regulates stemness, epithelial-mesenchymal transition and cisplatin sensitivity. J Exp Clin Cancer Res. 2018;37:287. https://doi.org/10.1186/s13046-018-0934-9.